UA93249C2 - Стабільна фармацевтична композиція, яка містить доцетаксел, і спосіб виготовлення такої композиції - Google Patents
Стабільна фармацевтична композиція, яка містить доцетаксел, і спосіб виготовлення такої композиціїInfo
- Publication number
- UA93249C2 UA93249C2 UAA200814650A UAA200814650A UA93249C2 UA 93249 C2 UA93249 C2 UA 93249C2 UA A200814650 A UAA200814650 A UA A200814650A UA A200814650 A UAA200814650 A UA A200814650A UA 93249 C2 UA93249 C2 UA 93249C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- same
- containing docetaxel
- stable pharmaceutical
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід стосується стабільної фармацевтичної композиції для ін'єкцій, що містить доцетаксел і циклодекстрин, причому додають щонайменше один водорозчинний полімер, вибраний з гідроксипропілметилцелюлози (НРМС), поліетиленгліколю (PEG) або полівінілпіролідону (PVP). Винахід також стосується способу одержання такої композиції.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20060045715 | 2006-05-22 | ||
KR1020070049340A KR100917809B1 (ko) | 2006-05-22 | 2007-05-21 | 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물 |
PCT/KR2007/002479 WO2007136219A1 (en) | 2006-05-22 | 2007-05-22 | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
UA93249C2 true UA93249C2 (uk) | 2011-01-25 |
Family
ID=65686631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200814650A UA93249C2 (uk) | 2006-05-22 | 2007-05-22 | Стабільна фармацевтична композиція, яка містить доцетаксел, і спосіб виготовлення такої композиції |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA93249C2 (uk) |
-
2007
- 2007-05-22 UA UAA200814650A patent/UA93249C2/uk unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY149627A (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
WO2009066955A3 (en) | Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same | |
WO2007084460A3 (en) | Pharmaceutical compositions with enhanced stability | |
Ulbricht et al. | On the biodegradability of polyethylene glycol, polypeptoids and poly (2-oxazoline) s | |
EA200870219A1 (ru) | Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения | |
CY1109425T1 (el) | Φαρμακευτικες συνθεσεις για τη χορηγηση με ελεγχομενη αποδεσμευση βιολογικα δραστικων ενωσεων | |
PE20060003A1 (es) | Formulacion farmaceutica polimerica para moldear por inyeccion | |
BRPI0615292A8 (pt) | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada | |
EA200900572A1 (ru) | Мицеллярные наночастицы с химическими субстанциями | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
BR112013016772B8 (pt) | compostos, uso do composto e composição farmacêutica | |
JO2932B1 (en) | Lyspro insulin compounds linked to PEG | |
WO2011015634A3 (en) | Controlled release formulations of lipocalin muteins | |
WO2009066956A3 (en) | Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same | |
EP2679244A3 (en) | Formulations which stabilize and inhibit precipitation of immunogenic compositions | |
MXPA06012583A (es) | Nanoparticulas pegiladas. | |
TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
WO2007056205A3 (en) | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents | |
EA201170512A1 (ru) | Композиция для перорального введения | |
WO2010045281A3 (en) | Stable aqueous formulations of water insoluble or poorly soluble drugs | |
EA201101286A1 (ru) | Композиции биодоступных капсул некристаллического соединения альфа-(n-сульфонамидо)ацетамина | |
WO2011056702A3 (en) | Fast dissolving/disintegrating coating compositions | |
UA89656C2 (uk) | Фармацевтична композиція, що диспергується перорально, і спосіб її приготування | |
UA93249C2 (uk) | Стабільна фармацевтична композиція, яка містить доцетаксел, і спосіб виготовлення такої композиції | |
WO2008033058A3 (fr) | Procédé permettant de produire une préparation d'insuline pour administration orale |